523 related articles for article (PubMed ID: 15717298)
21. Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.
Cassidy WM; Jones G; Williams K; Deforest A; Forghani B; Virella G; Venters C
J Adolesc Health; 2005 Mar; 36(3):187-92. PubMed ID: 15737773
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
23. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
[TBL] [Abstract][Full Text] [Related]
24. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
25. MMR vaccination: new thought.
Deshmukh V
Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
[No Abstract] [Full Text] [Related]
26. Prevalence of hepatitis B markers and measles, mumps, and rubella antibodies among Jewish refugees from the former Soviet Union.
Hurie MB; Gennis MA; Hernandez LV; Dindzans VJ; Davis JP
JAMA; 1995 Mar 22-29; 273(12):954-6. PubMed ID: 7884955
[TBL] [Abstract][Full Text] [Related]
27. The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales.
Sonnenberg P; Crowcroft NS; White JM; Ramsay ME
Arch Dis Child; 2007 Sep; 92(9):786-9. PubMed ID: 17412744
[TBL] [Abstract][Full Text] [Related]
28. Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.
MacLeod DR; Ing WK; Belcourt RJ; Pearson EW; Bell JS
Can Med Assoc J; 1975 Oct; 113(7):619-23. PubMed ID: 1181016
[TBL] [Abstract][Full Text] [Related]
29. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
32. Adult immunizations: update on recommendations.
Pham H; Geraci SA; Burton MJ;
Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
[TBL] [Abstract][Full Text] [Related]
33. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.
Giammanco G; Li Volti S; Salemi I; Giammanco Bilancia G; Mauro L
Eur J Epidemiol; 1993 Mar; 9(2):199-202. PubMed ID: 8519358
[TBL] [Abstract][Full Text] [Related]
34. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
[TBL] [Abstract][Full Text] [Related]
35. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
36. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
[TBL] [Abstract][Full Text] [Related]
37. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
Shinefield HR; Black S; Kuter BJ
J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
[TBL] [Abstract][Full Text] [Related]
38. Pediatric immunizations.
Edwards KM
Curr Probl Pediatr; 1993; 23(5):186-209. PubMed ID: 8354078
[TBL] [Abstract][Full Text] [Related]
39. Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Feb; 43(4):57-60. PubMed ID: 8295625
[TBL] [Abstract][Full Text] [Related]
40. [Post-transplantation vaccination of bone-marrow transplant recipients].
Adell C; Bayas JM; Vilella A; Perales M; Vidal J; Bertran MJ; Rojano X; Asenjo MA
Med Clin (Barc); 2002 Oct; 119(11):405-9. PubMed ID: 12381273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
